Novel anticoagulants and antiplatelet agents are a class of drugs designed to prevent blood clot formation in patients at risk of thrombotic events, such as stroke, heart attack, or deep vein thrombosis (DVT). These drugs work by targeting specific pathways in the coagulation cascade or platelet activation process to reduce clotting. Unlike traditional anticoagulants (like warfarin) and antiplatelet drugs (like aspirin), novel agents tend to offer benefits like more predictable effects, fewer drug interactions, and easier dosing schedules.
Key Topics:
Related Tags: Anticoagulant Drugs | Direct Oral Anticoagulants | Platelet Inhibitors | Thromboprophylaxis | Drug Mechanisms | Clinical Trials in Anticoagulation | Patient Monitoring | Blood Clot Prevention | Thrombosis Management
Related Societies: Society of Cardiovascular Patient Care | Thrombosis Canada